Table 1.
Waiting rooms | Reference period (July-December 2007) | Study period (July-December 2008) | |||||
---|---|---|---|---|---|---|---|
Number of contacts | Number of doses | Percent | Number of contacts | Number of doses | Percent | ||
Intervention group | GP1 | 3382 | 9 | 0.27 | 3154 | 31 | 0.98 |
GP2 | 3936 | 30 | 0.76 | 3931 | 37 | 0.94 | |
GP3 | 4533 | 13 | 0.29 | 4381 | 23 | 0.52 | |
Total | 11851 | 52 | 0.44(a)(b) | 11466 | 91 | 0.79(b)(d) | |
Control group | GP4 | 2816 | 19 | 0.67 | 2630 | 14 | 0.59 |
GP5 | 2413 | 5 | 0.21 | 2438 | 6 | 0.25 | |
GP6 | 3495 | 9 | 0.26 | 3575 | 14 | 0.39 | |
Total | 8724 | 33 | 0.38(a)(c) | 8643 | 34 | 0.39(c)(d) | |
Proportions were compared two by two by the chi-squared test and corresponding p-values are indicated by the same superscript as footnotes.
(a) 0.44 vs 0.38 (p = 0.50)
(b) 0.44 vs 0.79 (p = 0.0005)
(c) 0.38 vs 0.39 (p = 0.90)
(d) 0.79 vs 0.39 (p < 0.0001)